ZA824355B - Substituted imidazo (1,5-a) pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application - Google Patents
Substituted imidazo (1,5-a) pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic applicationInfo
- Publication number
- ZA824355B ZA824355B ZA824355A ZA824355A ZA824355B ZA 824355 B ZA824355 B ZA 824355B ZA 824355 A ZA824355 A ZA 824355A ZA 824355 A ZA824355 A ZA 824355A ZA 824355 B ZA824355 B ZA 824355B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyridines
- compounds
- manufacture
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/32—Compounds having groups or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27609481A | 1981-06-22 | 1981-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA824355B true ZA824355B (en) | 1983-04-27 |
Family
ID=23055137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA824355A ZA824355B (en) | 1981-06-22 | 1982-06-21 | Substituted imidazo (1,5-a) pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0068386B1 (en) |
| JP (1) | JPS58979A (en) |
| KR (1) | KR890002640B1 (en) |
| AR (1) | AR242032A1 (en) |
| AT (1) | ATE17004T1 (en) |
| AU (1) | AU559666B2 (en) |
| CA (1) | CA1250844A (en) |
| DE (1) | DE3268010D1 (en) |
| DK (1) | DK158227C (en) |
| ES (5) | ES513307A0 (en) |
| FI (1) | FI75569C (en) |
| GB (1) | GB2101595B (en) |
| GR (1) | GR76844B (en) |
| HU (1) | HU190701B (en) |
| IE (1) | IE53396B1 (en) |
| IL (1) | IL66101A (en) |
| NO (1) | NO159276C (en) |
| NZ (1) | NZ201023A (en) |
| PT (1) | PT75084B (en) |
| ZA (1) | ZA824355B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
| EP0098690B1 (en) * | 1982-06-14 | 1987-09-09 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use |
| US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
| US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
| ES2036128B1 (en) * | 1991-07-10 | 1993-12-16 | Menarini Lab | PROCEDURE FOR THE PREPARATION OF 4- (IMIDAZO) 1,5-A) PIRIDIN-8L) -1,4-DIHIDROPIRIDINAS. |
| US5468757A (en) * | 1994-01-31 | 1995-11-21 | Eli Lilly And Company | 6-azaindole thromboxane synthase inhibitors |
| PT1565463E (en) * | 2002-11-18 | 2008-09-10 | Novartis Ag | Imidazo[1,5a] pyridine derivatives and methods for treating aldosterone mediated diseases |
| EP2118101B1 (en) | 2007-03-09 | 2012-09-26 | Probiodrug AG | Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase |
-
1982
- 1982-06-18 GB GB08217704A patent/GB2101595B/en not_active Expired
- 1982-06-18 CA CA000405476A patent/CA1250844A/en not_active Expired
- 1982-06-18 FI FI822199A patent/FI75569C/en not_active IP Right Cessation
- 1982-06-21 AT AT82105426T patent/ATE17004T1/en not_active IP Right Cessation
- 1982-06-21 IE IE1458/82A patent/IE53396B1/en not_active IP Right Cessation
- 1982-06-21 ES ES513307A patent/ES513307A0/en active Granted
- 1982-06-21 EP EP82105426A patent/EP0068386B1/en not_active Expired
- 1982-06-21 GR GR68489A patent/GR76844B/el unknown
- 1982-06-21 HU HU822011A patent/HU190701B/en not_active IP Right Cessation
- 1982-06-21 PT PT75084A patent/PT75084B/en not_active IP Right Cessation
- 1982-06-21 NO NO822062A patent/NO159276C/en unknown
- 1982-06-21 NZ NZ201023A patent/NZ201023A/en unknown
- 1982-06-21 IL IL66101A patent/IL66101A/en not_active IP Right Cessation
- 1982-06-21 DE DE8282105426T patent/DE3268010D1/en not_active Expired
- 1982-06-21 DK DK277682A patent/DK158227C/en not_active IP Right Cessation
- 1982-06-21 AU AU85067/82A patent/AU559666B2/en not_active Ceased
- 1982-06-21 ZA ZA824355A patent/ZA824355B/en unknown
- 1982-06-21 KR KR8202756A patent/KR890002640B1/en not_active IP Right Cessation
- 1982-06-22 JP JP57106292A patent/JPS58979A/en active Granted
-
1983
- 1983-09-16 ES ES525689A patent/ES8502997A1/en not_active Expired
- 1983-09-16 ES ES525687A patent/ES525687A0/en active Granted
- 1983-09-16 ES ES525686A patent/ES525686A0/en active Granted
- 1983-09-16 ES ES525688A patent/ES525688A0/en active Granted
-
1984
- 1984-01-19 AR AR84295476A patent/AR242032A1/en active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3269625D1 (en) | Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use | |
| DE3269604D1 (en) | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them | |
| ZA81219B (en) | Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them | |
| ZA82158B (en) | New furo-(3,4-c)-pyridine derivatives, process of preparation of the same and therapeutical composition containing the same | |
| GB2086390B (en) | 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application | |
| EP0306871A3 (en) | 3,7-diazabicyclo û3,3,1¨ nonane compounds, process for their preparation and medicaments containing them | |
| ZA816322B (en) | N-oxides of n-oxacyclic-alkylpiperidines,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application | |
| GB2095668B (en) | Acylquinolinone derivatives process for their manufacture pharmaceutical preparations containing them and their use | |
| GB2101595B (en) | Substituted imidazo(1,5-a)pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application | |
| IL70485A (en) | Imidazo(1,5-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3265892D1 (en) | N-substituted 2-pyridyl indoles, process for their preparation, pharmaceutical compositions containing them, and their therapeutical use | |
| GB2073747B (en) | Triazolopyridinone compounds process for the preparation thereof and pharmaceutical preparations containing them | |
| ZA812034B (en) | Phrimidyl-quinazolines,process for their preparation pharmaceutical formulations containing these compounds,and their use | |
| HU908400D0 (en) | Process for the production of imidazo(4,5-c)pyridine derivatives and medical preparations containing these compounds as active agents | |
| DE3378208D1 (en) | Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds | |
| HUT38636A (en) | Process for production of derivatives of imidazo /1,2-a/ kynoline and medical preparatives containing there of | |
| DE3070304D1 (en) | Thiazolo(3,2-a)pyrimidine derivatives, process for preparing same, and drug containing same | |
| DE3261530D1 (en) | 1,4,9,10-tetrahydropyrazolo(4,3-e)pyrido(3,2-b)(1,4)diazepin-10-ones, process for their preparation and medicinal preparations containing them | |
| AR244211A1 (en) | Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and their therapeutical use | |
| IL65541A0 (en) | Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same | |
| EP0081461A3 (en) | Imidazobenzodiazepines, process for their preparation, pharmaceutical preparations containing these compounds and their therapeutical use | |
| EP0301245A3 (en) | 3-sulfonyl-3,7-diazabicyclo-(3,3,1)nonane compounds, processes for their preparation, and medicaments containing these compounds | |
| ZA817395B (en) | 1-carboxyalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application | |
| ZA817559B (en) | 1-carboxy-azaalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application | |
| HK42585A (en) | Novel oxothia compounds,processes for their preparation,pharmaceutical preparations containing these compounds and such compounds for therapeutic use |